OPCH Investor Alert: Levi & Korsinsky Investigates Option Care Health (OPCH) for Potential Securities Fraud

Option Care Health executives reaffirmed $5.8B-$6.0B revenue guidance on February 24, 2026, then slashed the range to $5.675B-$5.775B just 65 days later -- a reduction of up to 3.75%.  NEW YORK, May 13, 2026 /PRNewswire/ -- Shareholders who held Option Care Health (NASDAQ: OPCH) watched nearly 30% of their investment vanish after the company disclosed Q1 2026 results that missed revenue expectations and cut FY 2026 guidance by as much as $225 million from the top of the previously stated range.